Curative potential of allogeneic hematopoietic stem cell transplant in type 1 diabetes | Zendy

McCabe Kristen E. | Zendy; Pollock Allison J. | Zendy; Rehm Jennifer L. | Zendy; DeSantes Kenneth B. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Curative potential of allogeneic hematopoietic stem cell transplant in type 1 diabetes

Author(s) -

McCabe Kristen E.,

Pollock Allison J.,

Rehm Jennifer L.,

DeSantes Kenneth B.

Publication year - 2017

Publication title -

pediatric diabetes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.678

H-Index - 75

eISSN - 1399-5448

pISSN - 1399-543X

DOI - 10.1111/pedi.12430

Subject(s) - medicine , type 1 diabetes , aplastic anemia , haematopoiesis , savior sibling , hematopoietic stem cell transplantation , stem cell , diabetes mellitus , hematopoietic stem cell , type 2 diabetes , insulin , hematopoietic cell , intensive care medicine , immunology , transplantation , endocrinology , bone marrow , biology , genetics

The mainstay of treatment for type 1 diabetes ( T1D ) is exogenous insulin. Here, we report a case in which exogenous insulin requirements were eliminated after an allogeneic hematopoietic stem cell transplant for aplastic anemia in a pediatric patient recently diagnosed with T1D , and explore the validity of this approach compared with current treatments.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research